R. J. Thompson Et Al. , "Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis," JOURNAL OF HEPATOLOGY , vol.77, 2022
Thompson, R. J. Et Al. 2022. Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis. JOURNAL OF HEPATOLOGY , vol.77 .
Thompson, R. J., Gonzales, E., ARTAN, R., Hardikar, W., Lacaille, F., Lachaux, A., ... Roquelaure, B.(2022). Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis. JOURNAL OF HEPATOLOGY , vol.77.
Thompson, Richard Et Al. "Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis," JOURNAL OF HEPATOLOGY , vol.77, 2022
Thompson, Richard J. Et Al. "Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis." JOURNAL OF HEPATOLOGY , vol.77, 2022
Thompson, R. J. Et Al. (2022) . "Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis." JOURNAL OF HEPATOLOGY , vol.77.
@article{article, author={Richard J. Thompson Et Al. }, title={Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis}, journal={JOURNAL OF HEPATOLOGY}, year=2022}